JPWO2020009215A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020009215A5 JPWO2020009215A5 JP2020529058A JP2020529058A JPWO2020009215A5 JP WO2020009215 A5 JPWO2020009215 A5 JP WO2020009215A5 JP 2020529058 A JP2020529058 A JP 2020529058A JP 2020529058 A JP2020529058 A JP 2020529058A JP WO2020009215 A5 JPWO2020009215 A5 JP WO2020009215A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- luciferase
- seq
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108060001084 Luciferase Proteins 0.000 claims description 18
- 239000005089 Luciferase Substances 0.000 claims description 18
- 108090000331 Firefly luciferases Proteins 0.000 claims description 6
- 125000000539 amino acid group Chemical group 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 24
- 235000001014 amino acid Nutrition 0.000 claims 11
- 229940024606 amino acid Drugs 0.000 claims 11
- 150000001413 amino acids Chemical class 0.000 claims 9
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 3
- 235000018417 cysteine Nutrition 0.000 claims 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 3
- 229960000310 isoleucine Drugs 0.000 claims 3
- 229930182817 methionine Natural products 0.000 claims 3
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 3
- 239000004474 valine Substances 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 2
- 239000004472 Lysine Substances 0.000 claims 2
- 235000004279 alanine Nutrition 0.000 claims 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 229960001230 asparagine Drugs 0.000 claims 1
- 235000009582 asparagine Nutrition 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- 241000254064 Photinus pyralis Species 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018129384 | 2018-07-06 | ||
| JP2018129384 | 2018-07-06 | ||
| PCT/JP2019/026784 WO2020009215A1 (ja) | 2018-07-06 | 2019-07-05 | ルシフェラーゼ変異体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020009215A1 JPWO2020009215A1 (ja) | 2021-07-15 |
| JPWO2020009215A5 true JPWO2020009215A5 (https=) | 2022-07-08 |
| JP7472021B2 JP7472021B2 (ja) | 2024-04-22 |
Family
ID=69060439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020529058A Active JP7472021B2 (ja) | 2018-07-06 | 2019-07-05 | ルシフェラーゼ変異体 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20220064606A9 (https=) |
| JP (1) | JP7472021B2 (https=) |
| WO (1) | WO2020009215A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7385134B2 (ja) * | 2021-03-12 | 2023-11-22 | 東亜ディーケーケー株式会社 | 変異型甲虫ルシフェラーゼ、遺伝子、組換えベクター、形質転換体、及び変異型甲虫ルシフェラーゼの製造方法 |
| CN120457210A (zh) | 2023-01-27 | 2025-08-08 | 龟甲万株式会社 | 萤光素酶突变体 |
| CN119776293B (zh) * | 2024-12-06 | 2025-11-04 | 上海交通大学 | 一种ArsL突变体及其在合成Arsinothricin中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5229285A (en) * | 1991-06-27 | 1993-07-20 | Kikkoman Corporation | Thermostable luciferase of firefly, thermostable luciferase gene of firefly, novel recombinant dna, and process for the preparation of thermostable luciferase of firefly |
| EP2860252A1 (en) | 1997-09-19 | 2015-04-15 | Promega Corporation | Thermostable luciferases and methods of production |
| EP2221386B1 (en) * | 2007-11-20 | 2012-06-20 | Kikkoman Corporation | Composition for analysis of nucleic acid |
| JP2010081908A (ja) * | 2008-10-02 | 2010-04-15 | Hitachi Ltd | 変異型のホタルルシフェラーゼ |
| JP2011120559A (ja) * | 2008-12-26 | 2011-06-23 | Kikkoman Corp | ホタルルシフェラーゼ、その遺伝子、およびホタルルシフェラーゼの製造法 |
-
2019
- 2019-07-05 US US17/257,745 patent/US20220064606A9/en active Pending
- 2019-07-05 JP JP2020529058A patent/JP7472021B2/ja active Active
- 2019-07-05 WO PCT/JP2019/026784 patent/WO2020009215A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020009215A5 (https=) | ||
| AR128541A2 (es) | Métodos para modificar el punto isoeléctrico de anticuerpos mediante la sustitución de aminoácidos en la región de determinación de la complementariedad (cdr) | |
| TWI425076B (zh) | 咔唑衍生物及包含此衍生物之有機發光二極體 | |
| JP2017121261A5 (https=) | ||
| JP2019519216A5 (https=) | ||
| RU2013140685A (ru) | ВАРИАНТЫ Fc, СПОСОБЫ ИХ ПОЛУЧЕНИЯ | |
| RU2008135433A (ru) | Гибриды рекомбинантных антител-белков стресса | |
| JP2007513634A5 (https=) | ||
| TW201213497A (en) | Organic electroluminescent element | |
| AR040046A1 (es) | Anticuerpo neutralizante humano anti-igfr | |
| JP2005120106A5 (https=) | ||
| TW200722517A (en) | Process for production of polypeptide by regulation of assembly | |
| JP2021505156A5 (https=) | ||
| AU544256B2 (en) | Novel acylpeptides | |
| IL276170B2 (en) | Lipid-modified relaxin B peptide chains and their medical use | |
| JPWO2017090685A1 (ja) | Ｄｎａポリメラーゼ変異体 | |
| JP2015500864A5 (https=) | ||
| CN110892067A (zh) | 热稳定性提高的phi29DNA聚合酶突变体 | |
| DK1490492T3 (da) | Hybridt hepatocytvækstfaktorgen med höj ekspressionseffektivitet af to heterotyper af hepatocytvækstfaktor | |
| HRP20231175T1 (hr) | Postupci kultiviranja stanica | |
| RU2015147496A (ru) | Мишень для распыления, имеющая увеличенную энергетическую совместимость | |
| Morgan et al. | The partial structure of human plasma prealbumin and retinol-binding protein | |
| DK1309860T3 (da) | Fremgangsmåde til screening af peptider til anvendelse i immunterapi | |
| CN111689968A (zh) | 一种有机发光材料及其制备方法和应用 | |
| JP2005509160A5 (https=) |